ADMINISTRATION OF INSULIN

Size: px
Start display at page:

Download "ADMINISTRATION OF INSULIN"

Transcription

1 STANDARD OPERATING PROCEDURE ADMINISTRATION OF INSULIN Issue History First issued April 2012 Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote the safe administration of insulin for patients 2014 Named Responsible Officer:- Approved by Date Medicines Governance Pharmacist Quality, Patient Experience and Risk Group September 2012 Section:- Medicines Management SOPMM 11 Target Audience Registered UNLESS THIS VERSION HAS BEEN TAKEN DIRECTLY FROM TRUST WEB SITE THERE IS NO ASSURANCE THIS IS THE CORRECT VERSION

2 CONTROL RECORD Title Safe Administration of Insulin Purpose To promote the safe administration of insulin for patients Author Quality and Governance Service (QGS) and L Knight Impact Assessment Completed Yes No Actions Required Yes No Subject Experts Lisa Knight / Annie Baker Document Librarian QGS Groups consulted with :- Medicines Management Group Infection Control Approved YES Date formally approved by the 5 th September 2012 Quality, Patient Experience and Risk Group Method of distribution Intranet Archived Date: April 2012 Location: S Drive QGS Access Via QGS VERSION CONTROL RECORD Version Number Author Status Changes / Comments Version 1 Medicines Governance Pharmacist R Additional final check added to draw up insulin and check the amount of insulin drawn up against the PMAC to ensure the correct dose Version 2 Medicines Governance Pharmacist R prior to administration Additions to document to comply with the National Patient Safety Alert NPSA/2011/PSA003 Status New / Revised / Trust Change 2/10

3 NAME OF DIS C IPLINE : NUR S ING OB J E CTIVE S SCOPE TARGET GROUP (Staff who are authorised to follow standard operating procedure) CROSS REFERENCE R E L ATE D POLIC IE S EVIDENCE TO SUPPORT PROCEDURE To promote the safe administration of insulin for patients To cover all aspects of insulin administration, except the advanced preparation of insulin (see separate standard operating procedure) All registered nurses employed by the Trust involved in the administration of insulin Policies and Procedures Safe Handling and Administration of Medicines Policy Standard Operating Procedure for Medicine Administration Procedure for the Administration of Medication by Intra Muscular Route and Subcutaneous Route Incident Report Policy Record Keeping Procedure for Community Nursing Standard Operating Procedure (SOP) for Advanced Preparation of Insulin Procedure for Blood Glucose Monitoring Infection Control Policies Consent Policy NMC Standards for Medicine Management (2010) National Patient Safety Agency (2010) Rapid Response Report NPSA/2010/RRR013: Safer administration of insulin National Patient Safety Agency (2011) Patient Safety Alert NPSA/2011/PSA003: The Adult Patient s Passport to Safer Use of insulin PROCEDURE ACTIVITY RATIONALE RESPONSIBILITY 1. COLLECT PATIENT INFORMATION Nursing Staff could be requested to administer insulin to patients or to support self administration. It is essential that the nursing role is clearly defined in the patient s care plan It is important that the nurse is familiar with the type of insulin prescribed There are also several insulin devices available on the market, it is essential that the registered nurse is also familiar with the device prescribed. Whenever possible nurses should familiarise themselves with the insulin device in advance of seeing the patient. If nurses are unsure how to operate an insulin device, they must seek additional advice and support. To ensure appropriate treatment Different insulins have different onsets and durations of action To reduce risk of administration error To allow time to read manufacturer s instructions must work within their competency to reduce error Registered nurse 3/10

4 Always follow the manufacturer s instructions; each insulin device will have a manufacturer s user guide. If this information is not available in the nursing base, it will be supplied when the device is supplied to the patient, alternatively the manufacturer could be contacted for specific advice if an unfamiliar device has been prescribed and the user guide is not available. A copy of the manufacturer s instructions should be filed in patient s base and home records. Where appropriate the choice of device may be discussed with the prescriber or the Diabetic Specialist Nurse (DSN) if under care of a consultant The preferred devices for administration of insulin by a community nurse are disposable pens or insulin vials. The nurse should request to see the patient s Insulin Passport to confirm that the correct insulin product has been dispensed. If the patient does not have an Insulin Passport, where appropriate the nurse should confirm the product with the patient or carer. To promote safe use of device Copies are also available on The prescriber will ensure appropriate device selection Pens with cartridges are slightly more difficult to use To reduce risk of administering an incorrect insulin with a similar sounding name For patients who do not have an Insulin Passport or the passport needs updating refer to section CONS E NT Discuss risks and benefits of administration with the patient. Encourage the patient to read the manufacturer s patient information leaflet for full details of the insulin prescribed Patients can withdraw consent at any time To gain informed consent and document in patient s record Patients retain right to withdraw consent Registered Nurse 3. CHECK P ATIE NT ME DICINE S ADMINIS TR ATION CHAR T (PMAC) must check the Patient Medicines Administration Previous incidents show this step in Chart to ensure the dosage has not changed the safe administration of insulin was not completed resulting in medication errors Registered Nurse must also check the Record Chart of Insulin Administration and Blood Glucose Recording form to check the insulin has not already been administered Previous incidents have highlighted that if this step is not completed, patients have received double the dose of insulin The Patient Medicines Administration Chart must specify the following: 4/10 To reduce potential error (NPSA RR013)

5 Patient s full name Patient s date of birth The prescriber s signature and date prescribed The name of the insulin to be administered. (check the dispensed medicine is the same insulin as written on the PMAC) The device prescribed The number of units to be administered with word unit written out in full, in lower case and a space left between the dose and the word unit. The time and frequency of administration. (In some incidences the prescriber will indicate an appropriate window of time for administration. This needs to be on an individual patient basis. It is important to note, all regular doses of insulin should aim to be administered at the same time each day, including long acting insulins such as insulin glargine ) The route of administration i.e. subcutaneous injection Any known allergies Where there are any ambiguities the prescriber must be contacted for clarification It is also now recommended that the patient s NHS number is included on the PMAC 4. S TOR AG E OF INS ULIN Instruct the patient to store the insulin according to the manufacturer s instructions, insulin not in use should generally be kept in the main part of the refrigerator at 2 to 8ºC, not at the back of the fridge. Instruct patient to refer to the manufacturer s instructions for storage of insulin that is in use. To ensure the correct device is used for the patient The use of abbreviations have resulted in administration errors (NPSA RRR013) Failure to administer within the correct time interval may be detrimental to the patient. To comply with NPSA Safer Practice Notice To ensure safe storage of insulin Some insulins should not be stored in the fridge, when in use. Insulin that is in use and administered by the nursing service must be labelled with: 1. The full name of the patient 2. The date of commencement of the vial or pen (the date opened) 3. The date after which the insulin should no longer be administered. (the do not use after date) The name of the insulin, manufacturer s expiry date and the batch number must not be obscured with the additional label Each base will hold a supply of preprinted labels There may be situations where more than one person is prescribed insulin within a household or Care Home Insulin stored out of the fridge must usually be used within 28 days refer to manufacturer s literature for further details To ensure essential information is available. 5/10

6 The do not use after date and the manufacturer s expiry date, should be recorded on the Record Chart of Insulin Administration and Blood Glucose Recording form. Any expired insulin must be discarded. (see section 9) 5. PR E PAR ATION OF INS ULIN Collect together all essential equipment including, PMAC, Record Chart of Insulin Administration and Blood Glucose Recording form, insulin product to be administered, needles or if administering from a vial, insulin syringes. Decontaminate hands prior to procedure should not mix different insulins in the same syringe for administration. (For patients who have previously been prescribed insulin mixed in this way refer to the Diabetic Specialist Nurse for advice) Insulin must not be withdrawn from a cartridge via a syringe Always follow the manufacturer s instructions for the insulin device prescribed If using pen devices the needle must be changed prior to each administration A device specifically manufactured for the removal of needles should be used to change the needle If using vials, only insulin syringes must be used 6. ADMINIS TR ATION Check the time and frequency of the insulin administration (if the prescriber has indicated an appropriate window of time for administration this should be followed. In the absence of specific instructions nurses must administer insulin within one hour of the authorised time, this also applies to long acting insulin s, such as insulin glargine) If the prescribed time for administration has lapsed, the prescriber or other prescriber with responsibility for clinical care must be contacted for advice. The incident must be reported using the Trust incident reporting system. Ensure you are certain of the identity of the patient to whom the medicine is to be administered, by asking the patient and checking all available patient identifiers, such as name, date of birth or address To maintain an audit trail To ensure all necessary equipment is available To reduce the risk of transfer of transient micro organisms on the health care worker s hands To reduce risk of administration errors To reduce errors Certain devices require priming, prior to administration To prevent infection To reduce the risk of inoculation injury To reduce the risk of error Failure to administer within the correct time interval may be detrimental to the patient Additional blood glucose monitoring and or dose adjustment may be required To reduce administration errors 6/10

7 Check that the prescribed dose has not already been given, check Record Chart of Insulin Administration and Blood Glucose Record form first Extra care is needed when patients are prescribed two different doses of a particular insulin at different times of the day This is essential to reduce duplicate administration There have been several reported incidents where nurses have administered morning doses in the afternoon Check details on the PMAC correspond to pharmacy label Check manufacturer s expiry date and also if the insulin is already in use, check the do not use after date. Know and understand the contents of the current care plan for the administration of insulin (this must be updated every six months or earlier if health needs change) Draw up insulin and check the amount of insulin drawn up against the PMAC to ensure the correct dose prior to administration Where a patient is competent to do so, ask if the patient would like to double check the dose of insulin to be administered Comply with the Trust SOP for Administration of Medicines Administer the insulin by subcutaneous injection according to manufacturer s instructions In the event of nursing staff being unable to administer insulin as prescribed, it is essential that urgent advice is obtained from either, the patient s General Practitioner (GP), GP Out of Hours Service or the Registered Nurse s line manager depending on clinical circumstances. Reasons for insulin not been administered as prescribed could include: * Difficulties with the device * Unavailability of insulin * If there has been a significant delay in the time of administration The nurse must ensure adequate supplies of insulin are in the patient s home or on order to arrive in time for the next scheduled administration of insulin Decontaminate hands following procedure To reduce risk of expired stock being administered To deliver patient s health needs To ensure the correct dose of insulin is administered To empower the patient to take an active role in their treatment To reduce the risk of administration error To comply with safe practice It is imperative that the patient receives their insulin as prescribed. Delays in the administration of insulin may require the prescriber to adjust the dosage of insulin and extra monitoring of the patient may be required To reduce unsuccessful home visits or time wasted getting a new prescription and delaying administration of insulin the incident would need to be reported using the Trust incident reporting system. 7/10

8 If attending a care home Particular care is essential to check the identity of the patient The registered nurse must complete all checks and not rely on care staff. It is therefore strongly recommended that the registered nurse removes the insulin from the fridge her/himself. Ensure treatment occurs away from any distractions ideally in a separate treatment room with no other patient/resident in the same room 7. DOCUMENTATION Immediately after administration of the insulin, make a clear and accurate record of the administration on the Record of Insulin Administration and Blood Glucose Recording Form. must record information directly off the insulin product from the pen or the vial at each administration It is essential that nurses also record administration on the care home s Medicines Administration Record (MAR) Chart for cross reference 8. DIS POS AL OF SHARPS All sharps to be disposed of in an appropriate yellow lidded sharps container Sharps container will be provided by Community Nursing if the patient is on a Community Nursing Caseload. Becton, Dickinson and Company safe clip device should be used by the patient when away from home to dispose of the needle if appropriate Needles for disposal must not be resheathed, needles are to disposed of in the sharps container 9.DIS POS AL OF INS ULIN NO LONGER IN US E Advise patient to arrange for expired stock to be returned to the community pharmacy There may be residents within the home with similar names To reduce risk of medication errors To promote dignity and respect and reduce risk of medication error To ensure a robust audit trail and to reduce the risk of administration error To reduce the risk of inaccurate information being recorded The care home requires a record of all medicines administered to residents To comply with Sharps safety and management of contamination injuries policy Reduce risk of inoculation injuries To ensure safe disposal of medicines 10. ENSURE PATIENT HAS AN UP TO DATE CAR E PLAN Ensure patient has an up to date care plan which To ensure the care plan and insulin includes the actions to be taken in the event of dosage is current to the clinical need hypoglycemic or hyperglycemic episodes. The care plan must include who has clinical responsibility should any adverse clinical episode occur, as treatment may need to be adjusted in conjunction with the diabetic nurse specialist/ medical practitioner. All communications and actions taken must be evidenced in the patient s health records 8/10

9 Outside of core working hours (OOH), contact GP Out of Hours service. Ensuring all details of consultation are recorded in the patient s records and shared with the day staff To ensure all members of multidisciplinary team are updated Night staff are responsible for updating day staff of clinical concerns 11. PATIENTS WHO DO NOT HAVE INSULIN PASSPORTS OR THEIR PASSPORT REQUIRES UPDATING All patients prescribed insulin over the age of 18 To comply with NPSA/PSA/003 should be offered an Insulin Passport and the Trust s supporting patient information leaflet, The Safe Use of Insulin and You Registered nurses can supply patients with an Insulin Passport and supporting patient information leaflet, if they do not have a passport or their passport is misplaced. If a nurse issues an Insulin Passport and supporting patient information leaflet, the nurse must support the patient in completing the information on the passport, or complete the information required on the patient s To promote understanding behalf. The nurse should read through the leaflet with the patient and/or carer. It is also essential that the registered nurse informs the For the GP to document that an Insulin patient s GP if an Insulin Passport has been issued Passport has been issued If an error is detected on the Insulin Passport that could potentially lead to an administration error, this should be reported via the incident reporting system and the incorrect entry must be clearly crossed out. If the Insulin Passport requires updating, the nurse should support the patient in updating the passport or alternatively, update the passport on the patient s behalf. Any amendments made by the nurse must be clearly signed for and dated. If it is felt that it is inappropriate to issue an Insulin Passport or the patient refuses, this must be clearly documented in the patient record. 12 CLINICAL INCIDENT OR NEAR MISSES Any clinical incident or near misses must be reported using the Trust incident reporting system To help prevent future clinical incidents and learn from near misses in conjunction with the patient and or carer nurses 9/10

10 TR AINING SPECIALIST COMPETENCIES OR QUALIFIC ATIONS CONTINUING E DUC ATION & TR AINING RISK ASSESSMENTS ORGANISATION DEPARTMENT (IF APPLICABLE) employed by the Trust will work to the Standard Operating Procedure and related policies and procedures. All registered nurses will have completed their self assessment for Competency for Medicines Management within 3 months of joining organisation and updated two yearly Staff will have completed diabetes e-learning course within 3 months of joining Trust Staff will have attended Essential Learning every two years Staff will have attended Medicines Management Training every two years Staff will be aware of and comply with manufacturers instructions for specific medication and devices Staff have access to specialist nurses, line managers, General Practitioners and the Medicines Management Team for ongoing advice as required Risk of administration errors, risk of needle stick injuries Risk Assessment of patients with short term memory loss must be completed and updated every 6 months or earlier if clinical needs change Wirral Community NHS Trust Community Nursing STANDARD OPER ATING PR OCE DUR E (S OP) APPROVED BY:- Peer Review Forum Medicines Management Group Formal Approval Quality, Patient Experience and Risk Group 10/10

ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME

ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME STANDARD OPERATING PROCEDURE ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME First Issued July 08 Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote

More information

SAFE HANDLING OF VACCINES

SAFE HANDLING OF VACCINES STANDARD OPERATING PROCEDURE SAFE HANDLING OF VACCINES Issue History Issue Version One Purpose of Issue/Description of Change Planned Review Date To ensure vaccines are stored in accordance with manufacturers

More information

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices Name of Dental Practice : Objectives To ensure implementation of the regulations and guidance on safe and secure handling of midazolam and other controlled drugs (CDs) Scope To cover all aspects of obtaining

More information

Procedure for the prescribing and administration of insulin

Procedure for the prescribing and administration of insulin Procedure for the prescribing and administration of insulin Author: Lilian Baxendale and Heather Beadle Designation: Clinical Governance Pharmacists Version: Version 3 Date: December 2016 Date Approved:

More information

PROCEDURE FOR BLOOD GLUCOSE MONITORING

PROCEDURE FOR BLOOD GLUCOSE MONITORING PROCEDURE FOR BLOOD GLUCOSE MONITORING First Issued Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote safe and effective blood glucose monitoring using Trust equipment

More information

Pre-loading of insulin syringes for adult patients to administer at home

Pre-loading of insulin syringes for adult patients to administer at home Title: Directorate: Responsible for review: Ratified by: Diabetes - Pre-loading of insulin syringes for adult patients to administer at home Operations Samantha Rosindale, Diabetes Lead Champion Lynda

More information

Insulin Safety. Tracey Roe DSN SSOT partnership trust

Insulin Safety. Tracey Roe DSN SSOT partnership trust Insulin Safety Tracey Roe DSN SSOT partnership trust Insulin Type 1 Type 2 when oral therapies are not tolerated or contra/indicated Post MI Intercurrent illness Pre/peri/post op Gestational diabetes Painful

More information

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 Medication Safety Patient Safety Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 1 The patient journey Admission Ward Transfer Ward stay Discharge Medication storage and supply

More information

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the Document Details Title Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No 1506-41174 Local Ref (optional) Main points the Active immunisation against infection caused by Hepatitis

More information

Assistant Practitioner and Health Care Assistants Administration of Insulin, via Pen device, by Delegation Training and competency Toolkit

Assistant Practitioner and Health Care Assistants Administration of Insulin, via Pen device, by Delegation Training and competency Toolkit Assistant Practitioner and Health Care Assistants Administration of Insulin, via Pen device, by Delegation Training and competency Toolkit Document Summary The purpose of this policy is to guide and promote

More information

PROCEDURE FOR MANAGING AN ANAPHYLACTIC EMERGENCY

PROCEDURE FOR MANAGING AN ANAPHYLACTIC EMERGENCY MULTIDISCIPLINARY PROCEDURE PROCEDURE FOR MANAGING AN ANAPHYLACTIC EMERGENCY First Issued June 2011 Issue Version Four Purpose of Issue/Description of Change Planned Review Date To promote safe and consistent

More information

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients) Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients) Introduction This guideline is designed to provide a framework for patients to administer

More information

Community Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services

Community Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF HEPATITIS A VACCINE (HAVRIX MONODOSE VACCINE) BY REGISTERED NURSES WORKING IN THE COMMUNITY SUBSTANCE MISUSE TEAMS Version Number : 2 Patient Group

More information

Pre-Loaded Insulin Syringe Policy

Pre-Loaded Insulin Syringe Policy Pre-Loaded Insulin Syringe Policy Solent NHS Trust policies can only be considered to be valid and up-to-date if viewed on the intranet. Please visit the intranet for the latest version. Purpose of Agreement

More information

Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure

Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Quality Assurance Sub Committee Date ratified: 4 September

More information

Standard operating procedures for preparation and administration of intramuscular injections. No Action Rationale

Standard operating procedures for preparation and administration of intramuscular injections. No Action Rationale Standard operating procedures for preparation and administration of intramuscular injections Preparation Overview No Action Rationale 1 Collect and check all equipment 2 Check that the packaging of all

More information

North of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines

North of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines \ North of England Cancer Network Policies and Procedures Standards for the Safe Use of Oral Anticancer Medicines NECN Oral Anticancer medicine Policy version 1.6 Page 1 of 17 Issue Date: Feb 2017 Contents

More information

PATIENT GROUP DIRECTION PROCEDURE

PATIENT GROUP DIRECTION PROCEDURE PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen

More information

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group BEFORE USING THIS POLICY ALWAYS ENSURE YOU ARE USING THE MOST UP TO DATE VERSION Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical

More information

Care homes - Homely remedies

Care homes - Homely remedies Bulletin 72 August 2014 Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely remedy is a medicinal product

More information

Document Details. Patient Group Direction

Document Details. Patient Group Direction Document Details Title Patient Group Direction (PGD) Hepatitis B Vaccine (Engerix ) Trust Ref No 1505-41182 Local Ref (optional) Main points the Immunisation against Hepatitis B document covers Who is

More information

Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit

Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit Aim Review and rationalise the insulin quantities based on dosage instructions for diabetic patients in order to align

More information

PATIENT GROUP DIRECTION. Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif )

PATIENT GROUP DIRECTION. Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif ) PATIENT GROUP DIRECTION Administration of: Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif ) By: Practice Nurses In: General Practice It is the responsibility of the professional working under

More information

CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES

CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES National Patient Safety Alert RRR018 Preventing Fatalities From Medication Loading Doses (November 2010) MMCP05 CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES INTRODUCTION

More information

Care Homes - Homely Remedies Protocol

Care Homes - Homely Remedies Protocol Care Homes - Homely Remedies Protocol A homely remedy is a medicine for the short-term treatment of a minor ailment, such as indigestion, a cough, mild to moderate pain or constipation, and can be obtained

More information

Brook Green Centre for Learning. Policy and Guidance for Supporting Pupils with Medical Needs

Brook Green Centre for Learning. Policy and Guidance for Supporting Pupils with Medical Needs Brook Green Centre for Learning Policy and Guidance for Supporting Pupils with Medical Needs This document was written in line with recommendations made in the DfE s information pack Supporting Pupils

More information

AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS

AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS AUDIT TOOL FOR DISPENSING SERVICES COMPILED BY: Lynn Morrison ISSUE 1 CHECKED BY: Colette Byrne NUMBER: ISSUE DATE: 01.12.07 SUPERSEDES: NEW REVIEW DATE: 01.12.09 AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE

More information

Community Pharmacy Enhanced Service. Just In Case 4 Core Drugs supply. Stock Holding of Palliative Care Medicines

Community Pharmacy Enhanced Service. Just In Case 4 Core Drugs supply. Stock Holding of Palliative Care Medicines Community Pharmacy Enhanced Service Just In Case 4 Core Drugs supply Stock Holding of Palliative Care Medicines Parties to the Agreement Provider: Purchaser: NHS Blackpool 1. Service description 1.1 This

More information

Care homes - Homely remedies

Care homes - Homely remedies Bulletin 72 August 2014 Community Interest Company Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely

More information

Case scenarios: Patient Group Directions

Case scenarios: Patient Group Directions Putting NICE guidance into practice Case scenarios: Patient Group Directions Implementing the NICE guidance on Patient Group Directions (MPG2) Published: March 2014 [updated March 2017] These case scenarios

More information

POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE. September 2011

POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE. September 2011 POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE September 2011 WHSCT Policy for the safe use of oral methotrexate in secondary care Page 1 of 8 Policy Title Policy for the safe use of oral

More information

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Title Document Details Patient Group Direction (PGD) Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Trust Ref No 1445-36348 Local Ref (optional) Main points the document The treatment of

More information

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF PROCEDURE: Medicines Procedure: Patient Group Directions for the Administration of Hepatitis B Vaccine for SABP Drug and Alcohol Teams. PURPOSE OF PROCEDURE:

More information

SAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein

SAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein Patient Group Direction for the supply or administration of haemophilus influenzae type B and meningococcal conjugate vaccine to children requiring immunisation as part of the national childhood vaccination

More information

PATIENT GROUP DIRECTION (PGD)

PATIENT GROUP DIRECTION (PGD) PATIENT GROUP DIRECTION (PGD) SUPPLY OF NALOXONE HYDROCHLORIDE INJECTION BY REGISTERED NURSES TO CLIENTS BEING RELEASED FROM HMP FORD Version Number: 01HMP Patient Group Direction originally drawn up by:

More information

KEEPING SAFE WITH INSULIN THERAPY

KEEPING SAFE WITH INSULIN THERAPY KEEPING SAFE WITH INSULIN THERAPY kk WHY IS THIS LEAFLET FOR YOU? Insulin treatment improves the quality of life in many people and saves the lives of others. It is used to lower blood glucose levels.

More information

Developed By Name Signature Date

Developed By Name Signature Date Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:

More information

STANDARD OPERATING PROCEDURE. Supplying Insulin

STANDARD OPERATING PROCEDURE. Supplying Insulin STANDARD OPERATING PROCEDURE Supplying Insulin 2 Supplying insulin Contents Page Guidance notes 3 Appendix 1 Frequently asked questions 6 Appendix 2 Model standard operating procedure (SOP) 10 Useful references

More information

Sunderland Diabetes Network - Recommendations for safe prescribing of insulin.

Sunderland Diabetes Network - Recommendations for safe prescribing of insulin. Sunderland Diabetes Network - Recommendations for safe prescribing of insulin. Note: High strength insulins and biosimilar insulins are for specialist initiation only. They should not be initiated in primary

More information

CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES

CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES National Patient Safety Alert RRR018 Preventing Fatalities From Medication Loading Doses (November 2010) CP11 CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES INTRODUCTION The

More information

Patient Group Directions (PGDs)

Patient Group Directions (PGDs) Patient Group Directions (PGDs) Document level: Trustwide (TW) Code: MP2 Issue number: 4 Lead executive Authors details Type of document Target audience Document purpose Medical Director Senior Clinical

More information

Prescription only medicines (POMs)

Prescription only medicines (POMs) Prescription only medicines (POMs) 2017 Learning objectives Explain the legal framework with which registered health care professionals can administer prescription only medicines Define the role and limitations

More information

Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG

Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG Introduction This procedure is intended to encourage good practice in the management of opioid transdermal

More information

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In

More information

Document Details. Patient Group Direction

Document Details. Patient Group Direction Document Details Title Patient Group Direction (PGD) Salbutamol Aerosol Inhaler and salbutamol Nebulised Solution Trust Ref No 1569-34313 Local Ref (optional) Main points the document Treatment of acute

More information

GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against disease

More information

Guidance on Bulk Prescribing for Care Home Patients

Guidance on Bulk Prescribing for Care Home Patients Guidance on Bulk Prescribing for Care Home Patients Introduction Many patients in care homes taking medicines when required (PRN) can inevitably present problems for the prescriber in determining the quantity

More information

Public Health Dorset Prenoxad (Naloxone) Supply Standard Operating Procedure (SOP)

Public Health Dorset Prenoxad (Naloxone) Supply Standard Operating Procedure (SOP) Public Health Dorset Prenoxad (Naloxone) Supply Standard Operating Procedure (SOP) 1 Introduction 1.1 Purpose This SOP aims to provide guidance on the supply of take home naloxone, in the form of Prenoxad

More information

A patient guide to the use of insulin for diabetes

A patient guide to the use of insulin for diabetes A patient guide to the use of insulin for diabetes Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm

More information

Patient Safety Alert NPSA/2011/PSA003 The adult patient s passport to safer use of insulin

Patient Safety Alert NPSA/2011/PSA003 The adult patient s passport to safer use of insulin Patient Safety Alert NPSA/2011/PSA003 The adult patient s passport to safer use of insulin March 2011 Supporting Information Contents Page 1. About this document 2 2. Background 2 3. Scope 3 4. Review

More information

Clinician Responsible for Training and Review: Emergency Department Consultant

Clinician Responsible for Training and Review: Emergency Department Consultant Patient Group Direction for the supply and/or administration of Paracetamol Oral Suspension 250mg/5ml (Paracetamol paediatric suspension) to children receiving treatment from NHS Borders services. This

More information

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department

More information

Sunderland Diabetes Network - Recommendations for safe prescribing of insulin.

Sunderland Diabetes Network - Recommendations for safe prescribing of insulin. Sunderland Diabetes Network - Recommendations for safe prescribing of insulin. Note: High strength insulins and biosimilar insulins are for specialist initiation only. They should not be initiated in primary

More information

by registered nurses employed by NHS Hertfordshire or Hertfordshire GP Practices and signatories to the PGD

by registered nurses employed by NHS Hertfordshire or Hertfordshire GP Practices and signatories to the PGD Notice to all staff: NHS Hertfordshire Patient Group Directions (PGDs) may only be used by members of the healthcare professions named on the title page and only if each professional has individually been

More information

Advanced Preparation of Insulin Syringes for Adult Patients to Administer at Home

Advanced Preparation of Insulin Syringes for Adult Patients to Administer at Home Advanced Preparation of Insulin Syringes for Adult Patients to Administer at Home Guidance for nurses Third edition CLINICAL PROFESSIONAL RESOURCE ADVANCED PREPARATION OF INSULIN SYRINGES FOR ADULT PATIENTS

More information

Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business

Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business to Facilitate Compliance with Regulations 5(1)(g), 6, 8 and 11 of the Regulation of Retail Pharmacy Businesses

More information

GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation of individuals

More information

Adminstration of Insulin to Patients at Home and in Community Hospitals

Adminstration of Insulin to Patients at Home and in Community Hospitals 1929 Version 2 The Administration of Insulin to patients at home and in Community Hospitals Date: 26 January 2017 Adminstration of Insulin to Patients at Home and in Community Hospitals Page 1 of 7 Partners

More information

concentrate intravenous solution and other strong potassium solutions

concentrate intravenous solution and other strong potassium solutions Policy for the use of potassium chloride concentrate intravenous solution and other strong potassium solutions CLINICAL GUIDELINES ID TAG Policy for the use of potassium chloride Title: concentrate intravenous

More information

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

South Staffordshire and Shropshire Healthcare NHS Foundation Trust South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Immunisation Policy YELLOW - Clinical New or Replacing:

More information

All Saints First School Administering of Medicines Policy

All Saints First School Administering of Medicines Policy All Saints First School Administering of Medicines Policy Success Indicators The following indicators will demonstrate the level of compliance with this policy and its procedures: a) Employees who are

More information

Patient Group Directions Policy

Patient Group Directions Policy Patient Group Directions Policy Category: Summary: Equality Analysis undertaken: Valid From: Date of Next Review: Approval Date/ Via: Distribution: Related Documents: Author(s): Further Information: This

More information

Education and Training Committee 15 November 2012

Education and Training Committee 15 November 2012 Education and Training Committee 15 November 2012 Review of the process of approval of hearing aid dispenser pre-registration education and training programmes. Executive summary and recommendations Introduction

More information

Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control

Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control Unofficial translation /Ministry of Social Affairs and Health No. 548/2008 Government Decree on Narcotics Control Issued in Helsinki on 28 August 2008 Section 1 Scope of application This Decree lays down

More information

Developed By Name Signature Date

Developed By Name Signature Date Patient Group Direction 2156 version 2.0 Administration of Ipratropium 250mcg/ml Nebuliser Solution in Acute Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Date of

More information

PATIENT GROUP DIRECTIONS POLICY

PATIENT GROUP DIRECTIONS POLICY PATIENT GROUP DIRECTIONS POLICY To be read in conjunction with the Medicines Policy and the Controlled Drugs Policy Version: 5 Ratified by: Senior Managers Operations Group Date ratified: August 2015 October

More information

This document expires on Patient Group Direction No. VI 11

This document expires on Patient Group Direction No. VI 11 Patient Group Direction (PGD) for The Administration of Combined Inactivated Hepatitis A & Hepatitis B Vaccine (Twinrix adult, Twinrix paediatric) to Adults and Children over one year by Registered Nurses

More information

AUSTRALIAN AND NEW ZEALAND COLLEGE OF ANAESTHETISTS ABN

AUSTRALIAN AND NEW ZEALAND COLLEGE OF ANAESTHETISTS ABN PS51 (2009) AUSTRALIAN AND NEW ZEALAND COLLEGE OF ANAESTHETISTS ABN 82 055 042 852 GUIDELINES FOR THE SAFE ADMINISTRATION OF INJECTABLE DRUGS IN ANAESTHESIA 1. INTRODUCTION 1.1 Current data suggest that

More information

PATIENT SAFETY ALERT

PATIENT SAFETY ALERT PATIENT SAFETY ALERT PROBLEM: Research in UK and elsewhere has identified a risk to patients from errors occurring during intravenous administration of potassium solutions. Potassium chloride concentrate

More information

Procedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0

Procedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0 Procedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0 11 October 2017 Table of Contents 1. Introduction.. 3 2. Purpose of this Policy/Procedure. 3 3. Scope

More information

Administration of Hepatitis A and B Vaccine

Administration of Hepatitis A and B Vaccine PRACTICE: Ref No: PGD/ONEL/2011/006 Valid from December 2011 Valid to December 2013 Supersedes PGD: Any previous PGD used to administer Twinrix Adult and Paediatric vaccine Professional groups covered

More information

Administering Rescue Medication into Children for Prolonged Seizures

Administering Rescue Medication into Children for Prolonged Seizures Standard Operating Procedure 10 (SOP 10) Administering Rescue Medication into Children for Prolonged Seizures Why we have a procedure? Black Country Partnership NHS Trust (hereafter referred to as the

More information

Patient Group Direction for the Supply of Orlistat (Xenical) from Designated Community Pharmacies

Patient Group Direction for the Supply of Orlistat (Xenical) from Designated Community Pharmacies Patient Group Direction for the Supply of Orlistat (Xenical) from Designated Community Pharmacies Written by: Sheila Brown, Prescribing Adviser Date: September 2006 Reviewed by: Date: Ratified by: East

More information

SINGLE USE MEDICAL DEVICES POLICY

SINGLE USE MEDICAL DEVICES POLICY SINGLE USE MEDICAL DEVICES POLICY First Issued by/date BWW /BKW March 2001 Issue Version Purpose of Issue/Description of Change Planned Review Date 2 Update May 2011 Named Responsible Officer:- Approved

More information

CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY

CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY Version 4.0 March 2016 Review date March 2018 Introduction It is the purpose of this policy to provide clear guidelines that

More information

An overview of Patient Group Directions (PGDs)

An overview of Patient Group Directions (PGDs) An overview of Patient Group Directions (PGDs) The first stop for professional medicines advice Jo Jenkins Specialist Pharmacist Patient Group Directions SPS February 2018 Scope of SPS PGD service where

More information

This document expires on Patient Group Direction No. VI 5

This document expires on Patient Group Direction No. VI 5 Patient Group Direction (PGD) for The Administration of Combined Adsorbed Diphtheria, Tetanus, Pertussis, (Acellular Component) and Inactivated Poliomyelitis Vaccine (Infanrix-IPV ) to children aged between

More information

Good Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes

Good Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes Good Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes This good practice guidance is intended to be used as a framework for care home managers to adapt when writing their

More information

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Goulburn Region Preschool Association Inc.

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Goulburn Region Preschool Association Inc. DIABETES POLICY Mandatory Quality Area 2 The content of this policy was developed for KPV by advocacy and diabetes educators at Diabetes Australia Vic and the Royal Children s Hospital Melbourne s manager

More information

The Administration of Insulin to patients at home and in Community Hospitals

The Administration of Insulin to patients at home and in Community Hospitals The Administration of Insulin to patients at home and in Community Hospitals Partners in Care Document Ratification This is a controlled document and should not be altered in any way without the express

More information

Consultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off

Consultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off Policy For The Adjustment Of Insulin Injections By Paediatric Diabetes Specialist Nurses/Community Paediatric Nurses Diabetes Working With Children Within NHS Grampian Co-ordinators: Lead Paediatric Diabetes

More information

The prescribing newsletter for GPs, nurses and pharmacists NHS Northamptonshire Failure to respond to first choice antibiotics

The prescribing newsletter for GPs, nurses and pharmacists NHS Northamptonshire Failure to respond to first choice antibiotics Tablet Press EXTRA The prescribing newsletter for GPs, nurses and pharmacists NHS Northamptonshire Failure to respond to first choice antibiotics March 2017 Use of Buccolam (buccal midazolam) for breakthrough

More information

Patient Group Direction for GLUCAGON (Version 02) Valid From 1 October September 2019

Patient Group Direction for GLUCAGON (Version 02) Valid From 1 October September 2019 Version Control This PGD has been agreed by the following organisations FCMS Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history 31/07/17 V02

More information

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DRAFT GUIDANCE This guidance

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes The Newcastle upon Tyne Hospitals NHS Foundation Trust Pre-filled Patient Controlled Analgesia (PCA) syringes Version.: 2.2 Effective From: 1 June 2016 Expiry Date: 1 June 2019 Date Ratified: 20 April

More information

Unit 204 Assist with the assembly of prescribed items

Unit 204 Assist with the assembly of prescribed items Element 1 Assemble prescribed 171 172 Element 1 Assemble prescribed Background Assembling prescribed is a complex process. The two main components of this process are labelling and dispensing. It is essential

More information

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the

More information

Clinical Condition Indication:

Clinical Condition Indication: GG&C PGD ref no: 2012/943 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation of individuals

More information

This document expires on Patient Group Direction No. VI 7

This document expires on Patient Group Direction No. VI 7 Patient Group Direction (PGD) for The Administration of Combined low-dose Diphtheria, Tetanus, and Inactivated Polio Vaccine (Revaxis ) to individuals aged over 10 years, by Registered Nurses employed

More information

SHARED CARE PRESCRIBING GUIDELINE Triptorelin (Gonapeptyl Depot 3.75 mg TM, Decapeptyl SR mg TM ) for precocious puberty

SHARED CARE PRESCRIBING GUIDELINE Triptorelin (Gonapeptyl Depot 3.75 mg TM, Decapeptyl SR mg TM ) for precocious puberty WORKING IN PARTNERSHIP WITH SHARED CARE PRESCRIBING GUIDELINE Triptorelin (Gonapeptyl Depot 3.75 mg TM, Decapeptyl SR 11.25 mg TM ) for precocious puberty NHS Surrey s Medicines Management Committee classification:

More information

This document expires on Patient Group Direction Number VI 19

This document expires on Patient Group Direction Number VI 19 Patient Group Direction (PGD) for The Administration of Pneumococcal Polysaccharide Vaccine (PPV, Pneumovax II ) to adults over 65 years and at risk groups aged 2 years and over, by Registered Nurses employed

More information

Controlled Drugs Accountable Officers Network Scotland Executive Group. Gabapentin and Pregabalin - Frequently Asked Questions

Controlled Drugs Accountable Officers Network Scotland Executive Group. Gabapentin and Pregabalin - Frequently Asked Questions Gabapentin and Pregabalin - Frequently Asked Questions Gabapentin and pregabalin will become Schedule 3 Controlled Drugs in April 2019 NHS Contractor Services Prescribers are legally permitted to be in

More information

1. Intrathecal must never be abbreviated to IT on a prescription form True / False

1. Intrathecal must never be abbreviated to IT on a prescription form True / False Appendix 1: Intrathecal SACT Assessment Questions Core General Questions must be completed by all staff. 1. Intrathecal must never be abbreviated to IT on a prescription form 2. Intrathecal SACT must be

More information

INSULIN MANAGEMENT POLICY

INSULIN MANAGEMENT POLICY INSULIN MANAGEMENT POLICY To be read in conjunction with the Hypoglycaemia Management Policy for adult Patients and the Countywide Standard Operating Procedure for Implementing the Insulin Passport/Safety

More information

PLEASE READ THIS USER MANUAL BEFORE USE

PLEASE READ THIS USER MANUAL BEFORE USE USER MANUAL Humalog 200 units/ml KwikPen, solution for injection in a pre-filled pen insulin lispro PLEASE READ THIS USER MANUAL BEFORE USE USE ONLY IN THIS PEN, OR SEVERE OVERDOSE CAN RESULT Read the

More information

PGD No Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 - Gardasil - September 2012

PGD No Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 - Gardasil - September 2012 Notice to all staff: NHS Hertfordshire Patient Group Directions (PGDs) may only be used by members of the healthcare professions named on the title page and only if each professional has individually been

More information

Intrathecal. By the end of this chapter, you will be able to: Introduction. Chapter 20

Intrathecal. By the end of this chapter, you will be able to: Introduction. Chapter 20 Chapter 20 Intrathecal Preparations By the end of this chapter, you will be able to: l Describe the specific risks with intrathecal cytotoxic products l List five checks that need to be carried out on

More information

Dispensing and administration of emergency opioid antagonist without a

Dispensing and administration of emergency opioid antagonist without a 68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies

More information

Expiry Date: September 2009 Template Version: Page 1 of 7

Expiry Date: September 2009 Template Version: Page 1 of 7 GG&C PGD ref 2007/467 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria:

More information

Guidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception

Guidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception Guidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception Pharmaceutical Society of Ireland Version 4 December 2016 Updates made following

More information